Category: News & Events

Guideline-Directed Medical Therapy in Heart Failure: The Need for Speed

Guideline-directed medical therapyAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. Heart failure (HF) represents one of the most pressing health challenges globally, affecting more than 64 million people worldwide. Despite therapeutic progress, HF remains a leading cause of hospitalization and mortality, particularly in patients with reduced ejection fraction (HFrEF), with annual costs, including hospitalizations, pharmacotherapy, and productivity losses, measured in the hundreds of billions of dollars. Readmissions remain common: roughly one in four patients is rehospitalized within 30 days in many healthcare (more…)

Loading

Clinical Applications of Magnetocardiography in Cardiovascular Medicine: Technological Advances, Challenges, and Future Perspectives

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Recent advancements in medical technology have markedly improved the management and treatment outcomes of cardiovascular diseases (CVD) in China. However, because of widespread unhealthful lifestyle choices, such as smoking and alcohol consumption, the incidence and mortality rates of CVD remain alarmingly high. Early detection and accurate diagnosis are therefore critical to mitigating the health risks associated with CVD.

(more…)

Loading

The Second Valve Drag and Reposition Technique for Rescue of Self-Expanding Aortic Valve Migration into the Left Ventricle during Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This article reports a successful rescue technique for valve migration during transcatheter aortic valve replacement (TAVR) in a high-risk patient with pure aortic regurgitation, a condition that poses major anchoring challenges due to the lack of calcification. In this case, downward migration of the initially implanted valve caused paravalvular leak and impaired mitral valve function.

(more…)

Loading

Circulating TGM2 Levels as a Prognostic Biomarker for Coronary Artery Disease Severity and Major Adverse Cardiac Events in Acute Coronary Syndrome

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transglutaminase 2 (TGM2) has been implicated in various health conditions, yet its role in acute coronary syndrome (ACS) remains poorly characterized in clinical settings. This study investigated the association between circulating TGM2 levels and the severity of coronary stenosis in ACS.

A total of 242 individuals with ACS were included in this study. Clinical data were collected, and the severity of coronary stenosis was evaluated with the Gensini and Syntax scoring systems. Kaplan-Meier analysis, logistic regression, and receiver operating characteristic (ROC) curve analysis were performed.

(more…)

Loading

Association Between Serum Uric Acid Levels and Atrial Fibrillation Burden

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study investigated the association between serum uric acid (UA) levels and atrial fibrillation (AF) burden in Chinese patients with AF.

In this cross-sectional study, AF burden was defined as the proportion of AF duration to total monitoring time, recorded by a patch device over ≥24 hours. Serum UA levels were measured at the start of monitoring. Multivariate logistic regression was used to assess associations.

(more…)

Loading

Exploring Biomarkers for Early Diagnosis of Abdominal Aortic Aneurysms

Announcing a new article publication for Cardiovascular Innovations and Applications journal examines recent advances in circulating biomarkers for the early diagnosis and risk assessment of abdominal aortic aneurysm (AAA), a largely asymptomatic but potentially life-threatening vascular condition. The authors describe how pathological processes underlying AAA—such as inflammation, vascular smooth muscle cell dysfunction, extracellular matrix degradation, and thrombosis—release measurable molecular signals into the bloodstream, creating opportunities to improve detection beyond imaging alone.

(more…)

Loading

Effects of Rivaroxaban on Prognosis in Patients with Acute Myocardial Infarction and Preexisting Atrial Fibrillation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. A new real-world analysis using data from the Tianjin Health and Medical Big Data Super Platform provides the first large-scale clinical insights from Asia into anticoagulation practices for patients with acute myocardial infarction (AMI) and preexisting atrial fibrillation (AF), a population known to be at heightened risk for adverse cardiovascular events.

(more…)

Loading

The Role of Immune Cells and Inflammatory Proteins in Aortic Dissection

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  Aortic dissection (AD) is one of the most life-threatening emergencies in cardiovascular diseases, with mortality rates increasing by 1%-2% per hour in untreated Stanford type A AD patients, exceeding 55% within 48 hours. Therefore, investigating the mechanisms underlying AD pathogenesis and developing effective interventions are critically important. The pathological changes in AD primarily result from degeneration of the aortic media, leading to loss of elasticity and reduced resistance to mechanical stress, ultimately causing rupture of the medial layer and formation of a false lumen.

(more…)

Loading

Targeting Immune Mechanisms in Myocardial Infarction – From Bioinformatic Discovery to Therapeutic Translation

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  It is abundantly clear that the immune system plays an increasingly pivotal role in Myocardial Infarction pathogenesis and repair. The discovery of key immune factors, such as S100A12 and BCL6, have not only deepened our understanding of the disease mechanism, but also elucidated novel pathways for precise diagnosis and targeted intervention. Critically, emerging modalities, including cellular therapies, nanodelivery systems, and intelligent immunomodulation strategies, are rapidly transitioning from preclinical validation to clinical application, offering transformative approaches for long-term cardiac preservation and enhanced cardiac event reduction. Future breakthroughs in MI precision medicine will depend on resolving the spatiotemporal balance between inflammation control and tissue regeneration, ultimately enabling personalized interventions centered on dynamic immune microenvironment modulation.

(more…)

Loading

Extracellular Vesicle-Derived miRNA in Acute Myocardial Infarction

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  EV-miRNA-based precision diagnostics and targeted therapeutic strategies represent the frontier of personalized medicine. By integrating multi-omics data, developing highly sensitive molecular detection platforms, and advancing intelligent delivery systems, the continuum of prevention and management from Acute Myocardial Infarction to heart failure is progressively evolving into a comprehensive, multi-dimensional precision paradigm. This progress holds great promise for shifting clinical practice from population-based empirical treatments towards individualized, mechanism-driven therapies.

(more…)

Loading